Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Marie-Therese Haider"'
Autor:
Arun Everest‐Dass, Stepan Nersisyan, Hanna Maar, Victor Novosad, Jennifer Schröder‐Schwarz, Vera Freytag, Johanna L. Stuke, Mia C. Beine, Alina Schiecke, Marie‐Therese Haider, Malte Kriegs, Omar Elakad, Hanibal Bohnenberger, Lena‐Christin Conradi, Maria Raygorodskaya, Linda Krause, Mark vonItzstein, Alexander Tonevitsky, Udo Schumacher, Diana Maltseva, Daniel Wicklein, Tobias Lange
Publikováno v:
Molecular Oncology, Vol 18, Iss 1, Pp 62-90 (2024)
Hematogenous metastasis limits the survival of colorectal cancer (CRC) patients. Here, we illuminated the roles of CD44 isoforms in this process. Isoforms 3 and 4 were predominantly expressed in CRC patients. CD44 isoform 4 indicated poor outcome and
Externí odkaz:
https://doaj.org/article/c19589a2bdca416b84704f2b8e082ac3
Autor:
Marie-Therese Haider, Jennifer Zarrer, Nicole Ridlmaier, Rafael Preuer, Daniel J. Smit, Hiroaki Saito, Eric Hesse, Hanna Taipaleenmäki
Publikováno v:
Journal of Bone Oncology, Vol 45, Iss , Pp 100541- (2024)
Externí odkaz:
https://doaj.org/article/05f96b54edf94764848a229e40ef0d59
Autor:
Marie-Therese Haider, Hiroaki Saito, Jennifer Zarrer, Kevin Uzhunnumpuram, Sankari Nagarajan, Vijayalakshmi Kari, Michael Horn-Glander, Stefan Werner, Eric Hesse, Hanna Taipaleenmäki
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-16 (2020)
Abstract Background Osteoclast activation is a hallmark of breast cancer-induced bone disease while little is known about the role of osteoblasts in this process. Recently, we identified the homeodomain protein TG-interacting factor-1 (Tgif1) as a cr
Externí odkaz:
https://doaj.org/article/28643997978b46f4b5443bc1c142b650
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The establishment of bone metastasis remains one of the most frequent complications of patients suffering from advanced breast cancer. Patients with bone metastases experience high morbidity and mortality caused by excessive, tumor-induced and osteoc
Externí odkaz:
https://doaj.org/article/dbc0e9e155fe4c6987efa2bc35839a28
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6, p 2898 (2021)
Patients with advanced breast cancer are at high risk of developing bone metastasis. Despite treatment advances for primary breast cancer, metastatic bone disease remains incurable with a low relative survival. Hence, new therapeutic approaches are r
Externí odkaz:
https://doaj.org/article/278cde3825e44b97a6d163b051f5d3f1
Autor:
Daniel J. Smit, Laure Cayrefourcq, Marie-Therese Haider, Nico Hinz, Klaus Pantel, Catherine Alix-Panabières, Manfred Jücker
Publikováno v:
Cells, Vol 9, Iss 9, p 2129 (2020)
Circulating tumor cells (CTCs) are cells shed from the primary tumor into the bloodstream. While many studies on solid tumor cells exist, data on CTCs are scarce. The mortality of cancer is mostly associated with metastasis and recent research identi
Externí odkaz:
https://doaj.org/article/d8dd65753d1443c0a8cfb990c0597526
Publikováno v:
Biomolecules, Vol 10, Iss 2, p 337 (2020)
Bone is the most common metastatic site in breast cancer. Upon arrival to the bone, disseminated tumor cells can undergo a period of dormancy but often eventually grow and hijack the bone microenvironment. The bone marrow microenvironment consists of
Externí odkaz:
https://doaj.org/article/e0be35a04abc4f2e8ebce4b8a184218a
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Bone metastases are a common and devastating feature of late-stage breast cancer. Metastatic bone disease is a consequence of disturbed bone remodeling due to pathological interactions between cancer cells and the bone microenvironment (BME). In the
Externí odkaz:
https://doaj.org/article/9635885b37b54a1c9beb0be71ec75182
Autor:
Kavitha Chinnaiya, Michelle A. Lawson, Sally Thomas, Marie-Therese Haider, Jenny Down, Andrew D. Chantry, David Hughes, Antony Green, Jon R. Sayers, John A. Snowden, Martin P. Zeidler
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
Externí odkaz:
https://doaj.org/article/c40f1dd8c0f64b22baa2be92f819adfa
Autor:
Sandra S. McAllister, David T. Scadden, Robert E. Coleman, Janet E. Brown, Ingunn Holen, Ana C. Garrido-Castro, Walter M. Gregory, Yuanbo Qin, Catherine S. Rhee, Marie-Therese Haider, John N. Hutchinson, Jaclyn Sceneay, Molly J. DeCristo, Nicolas Severe, Ninib Baryawno, Jessalyn M. Ubellacker
Supplemental Figure 1 shows the tumor masses of the subcutaneous tumors shown in Figure 1, as well as the flow cytometry gating strategy of M/OCP populations and the osteoclast differentiation assay experimental schematic. Supplemental Figure 2 shows
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9f95d1649bc441c5a0ff4e4e93ee25
https://doi.org/10.1158/0008-5472.22419630.v1
https://doi.org/10.1158/0008-5472.22419630.v1